News

After almost 3 months of suspension due to COVID-19, the PRESTIGE-AF Study has resumed recruitment of participants.

Following the successful bid for funding from the European Commission, the PRESTIGE-AF Consortium members came together for the project's kick-off meeting which took place on Wednesday 6th December 2017 and hosted by Imperial College London.

A new 6,9 million euro initiative has been launched with the aim of enhancing more established measures around Stroke prevention in patients with a heart condition called atrial fibrillation (AF) who have previously had a stroke caused by bleeding in the brain (termed intracerebral haemorrhage or ICH).